Predictors of the 10-year direct costs for treating multiple sclerosis.

Moccia, M; Palladino, R; Lanzillo, R; Triassi, M; Brescia Morra, V

Moccia, M; Palladino, R; Lanzillo, R; Triassi, M; Brescia Morra, V.

Affiliation

Moccia M; Multiple Sclerosis Clinical Care and Research Centre, Department of Neuroscience, Reproductive Science and Odontostomatology, Federico II University, Naples, Italy.
Palladino R; Department of Primary Care and Public Health, Imperial College, London, UK.
Lanzillo R; Department of Public Health, Federico II University, Naples, Italy.
Triassi M; Multiple Sclerosis Clinical Care and Research Centre, Department of Neuroscience, Reproductive Science and Odontostomatology, Federico II University, Naples, Italy.
Brescia Morra V; Department of Public Health, Federico II University, Naples, Italy.

Acta Neurol Scand ; 135(5): 522-528, 2017 May.

Article in En | MEDLINE | ID: mdl-27357245

Subject(s)

Disease Progression; Health Care Costs/trends; Multiple Sclerosis/drug therapy; Multiple Sclerosis/economics; Adult; Cohort Studies; Female; Forecasting; Humans; Male; Middle Aged; Outcome Assessment, Health Care; Prospective Studies; Retrospective Studies; Time Factors; Treatment Outcome

Key words

cost; disease-modifying treatment; economic; multiple sclerosis; progression; relapse; treatment

Fulltext

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Health context: 1_ASSA2030 Database: MEDLINE Main subject: Health Care Costs / Disease Progression / Multiple Sclerosis Type of study: Etiology_studies / Health_economic_evaluation / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Adult / Female / Humans / Male / Middle aged Language: En Journal: Acta Neurol Scand Year: 2017 Document type: Article

Fulltext

XML

PubMed Links

Search on Google